Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Update

5 Feb 2018 07:14

RNS Number : 8852D
Electrocomponents PLC
05 February 2018
 

 

Electrocomponents plc today issues a trading update for the four-month period to 31 January 2018.

 

Underlying revenue growth(1)

Region

Q1 to June 2017

Q2 to Sept 2017

4 months to 31 Jan 2018

 

Northern Europe

 

10%

 

12%

13%

Southern Europe

10%

12%

11%

Central Europe

11%

14%

17%

Total Europe

10%

13%

13%

Asia Pacific

18%

17%

22%

The Americas

16%

15%

12%

Group

13%

14%

14%

 

Our strong underlying revenue (1) performance in H1 has continued into the first four months of H2. The market backdrop remains positive and we continue to execute well with improvements in areas such as customer experience, digital and sales effectiveness driving further market share gains.

· In the four months to 31 January 2018, Group underlying revenue growth remained strong at 14%, with all of our five regions continuing to see double-digit underlying revenue growth.

o Strong momentum in digital with 15% underlying revenue growth in the period reflecting success with our digital marketing strategy and improved online experience.

o A further acceleration in underlying revenue growth at RS Pro, our own-brand business, which grew at 14% during the period (+10% in H1).

· We remain on track to deliver stable gross margin for the full year to March 2018.

· At the end of this financial year we will have completed the first phase of the Performance Improvement Plan and delivered cumulative annualised savings of £30 million. We are currently examining new initiatives to further simplify the way we do business and generate efficiency.

 

Lindsley Ruth, Chief Executive Officer, commented

"Our performance year to date has been pleasing and we are confident of delivering strong progress in the current financial year. The first phase of the Performance Improvement Plan is now complete, but we still believe we have a significant further opportunity to improve efficiency and reduce complexity allowing continued strong growth at higher operating margins. We remain excited by the opportunity for growth and improvement."

 

LEI: 549300KVXDURRKVW7R37

 

Enquiries:

David Egan

Group Finance Director

0207 239 8400

Polly Elvin

Investor Relations and Corporate PR

0207 239 8427

Martin Robinson/David Allchurch

Tulchan Communications

0207 353 4200

 

Notes:

1. Revenue growth rates, unless otherwise stated, are adjusted for trading days and currency movements ("underlying revenue growth/decline").

2. During the year to March 2018 we expect to see around a £24 million adverse impact on revenue from fewer trading days compared with FY 2017. In the year to March 2019 we expect to see a positive impact of around £9 million on revenue from additional trading days compared with FY 2018.

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. The average H1 exchange rates for Euro and US $ respectively were €1.14 and $1.29. Ten months to 31 January average spot rates for Euro and US $ respectively are €1.13 and $1.31. Assuming 31 January spot rates continue for the balance of the year our average exchange rates for Euro and US $ for the year would be €1.13 and $1.32. Every 1 cent movement in the Euro will have a circa £1.2 million impact on profit. Every 1 cent movement in US $ will have a circa £0.4 million impact on profit.

 

 

 

Electrocomponents plc - Conference Call Dial in Instructions

Date:

Monday 5 February

UK Time:

08.00h call

Telephone number:

+44 (0) 1452 541003

PIN:

9377237

Chairman:

Lindsley Ruth

Electrocomponents plc - Replay Dial in Instructions (available until Monday 12 February)

Telephone number:

+44 (0) 1452 550000

PIN:

9377237

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVABRWAAURRR
Date   Source Headline
11th Sep 20208:50 amRNSDirector Declaration
7th Sep 20204:06 pmRNSDirector/PDMR Shareholding
2nd Sep 20201:58 pmRNSDirector/PDMR Shareholding
1st Sep 202010:57 amRNSTotal Voting Rights
3rd Aug 20209:52 amRNSBlock listing Interim Review
16th Jul 20204:53 pmRNSResult of AGM
7th Jul 20207:00 amRNSTrading Statement
1st Jul 20204:03 pmRNSDirector/PDMR Shareholding
1st Jul 202010:04 amRNSTotal Voting Rights
23rd Jun 20209:30 amRNSNotice of Trading Update
16th Jun 202012:59 pmRNSAnnual Financial Report
10th Jun 20204:37 pmRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSFinal Results
4th May 202010:00 amRNSNotice of 2020 Full-Year Results
1st May 20209:46 amRNSTotal Voting Rights
30th Apr 202012:20 pmRNSDisclosure of Rights Attached to Ordinary Shares
1st Apr 20209:33 amRNSTotal Voting Rights
27th Mar 20209:00 amRNSAdditional Listing
23rd Mar 20207:00 amRNSTrading Statement
12th Mar 202012:24 pmRNSDirector/PDMR Shareholding
12th Mar 202011:45 amRNSDirector/PDMR Shareholding
5th Mar 20203:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20209:55 amRNSTotal Voting Rights
4th Feb 20207:01 amRNSDirector illness
4th Feb 20207:00 amRNSTrading Statement
3rd Feb 20209:01 amRNSBlock listing Interim Review
3rd Feb 20209:00 amRNSTotal Voting Rights
23rd Jan 202010:30 amRNSNotice of Trading Update
2nd Jan 20209:00 amRNSTotal Voting Rights
16th Dec 20193:41 pmRNSDirectorate Change
2nd Dec 20199:00 amRNSTotal Voting Rights
27th Nov 201910:30 amRNSValue-added solutions investor day
12th Nov 20197:00 amRNSHalf-year Report
11th Nov 20197:00 amRNSDirector illness
1st Nov 20199:00 amRNSTotal Voting Rights
10th Oct 201910:00 amRNSDirector Declaration
8th Oct 20197:00 amRNSTrading Statement
1st Oct 201912:30 pmRNSTotal Voting Rights
24th Sep 20191:05 pmRNSDirectorate Change
24th Sep 201911:01 amRNSNotice of Trading Update
2nd Sep 201912:54 pmRNSDirectorate Change
2nd Sep 201911:41 amRNSBlock listing Interim Review
2nd Sep 201911:27 amRNSTotal Voting Rights
23rd Aug 20199:00 amRNSHolding(s) in Company
1st Aug 201910:01 amRNSTotal Voting Rights
26th Jul 20192:28 pmRNSElectrocomponents plc signs private placement
24th Jul 201910:41 amRNSDirector/PDMR Shareholding
19th Jul 201910:09 amRNSDirector/PDMR Shareholding
17th Jul 201912:05 pmRNSResult of AGM
15th Jul 20194:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.